Naomi Allen

• Comparison of sociodemographic and health-related characteristics of UK Biobank participants with the general population

  Fry A. et al, (2017), American Journal of Epidemiology

• UK Biobank: Opportunities for cardiovascular research

  Littlejohns TJ. et al, (2017), European Heart Journal

• Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.

  Fortner RT. et al, (2017), Int J Cancer, 140, 1317 - 1323

• Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research.

  Littlejohns TJ. et al, (2016), Cancer Epidemiol, 45, 40 - 46

• Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies.

  Wu K. et al, (2016), Int J Cancer, 138, 2368 - 2382

• A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

  Travis RC., (2016), Cancer Research

• Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.

  Price AJ. et al, (2016), European urology

• An epidemiological model for prediction of endometrial cancer risk in Europe.

  Hüsing A. et al, (2016), Eur J Epidemiol, 31, 51 - 60

• Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.

  Key TJ. et al, (2015), Am J Clin Nutr, 102, 1142 - 1157

• Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study.

  Sen A. et al, (2015), Br J Cancer, 113, 840 - 847

• Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study

  Sen A. et al, (2015), British Journal of Cancer, 113, 840 - 847

• UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.

  Sudlow C. et al, (2015), PLoS Med, 12

• Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP.

  Cheng TH. et al, (2015), Eur J Hum Genet, 23, 260 - 263

• Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study.

  Bhoo-Pathy N. et al, (2015), Breast Cancer Res, 17

• Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.

  Tsilidis KK. et al, (2015), Int J Cancer, 136, 372 - 381

• Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.

  Wang Z. et al, (2014), Hum Mol Genet, 23, 6616 - 6633

• Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial.

  Tsilidis KK. et al, (2014), Diabetes Care, 37, 2522 - 2532

• Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.

  Crowe FL. et al, (2014), J Natl Cancer Inst, 106

• Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition.

  Schmidt JA. et al, (2014), Cancer Epidemiol Biomarkers Prev, 23, 976 - 985

• Adherence to the Mediterranean diet and risk of bladder cancer in the EPIC cohort study.

  Buckland G. et al, (2014), Int J Cancer, 134, 2504 - 2511

• Adherence to the Mediterranean diet and risk of bladder cancer in the EPIC cohort study

  Buckland G. et al, (2014), International Journal of Cancer, 134, 2504 - 2511

• Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Turney BW. et al, (2014), Eur J Epidemiol, 29, 363 - 369

• First-morning urinary melatonin and breast cancer risk in the Guernsey Study.

  Wang XS. et al, (2014), Am J Epidemiol, 179, 584 - 593

• First-morning urinary melatonin and breast cancer risk in the guernsey study

  Wang XS. et al, (2014), American Journal of Epidemiology, 179, 584 - 593

• UK biobank data: come and get it.

  Allen NE. et al, (2014), Sci Transl Med, 6

• Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC)

  Turney BW. et al, (2014), European Journal of Epidemiology, 29, 363 - 369

• The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study.

  Bergmann MM. et al, (2013), Int J Epidemiol, 42, 1772 - 1790

• A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk.

  Baltar VT. et al, (2013), Eur J Epidemiol, 28, 677 - 688

• Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).

  Tsilidis KK. et al, (2013), Int J Cancer, 133, 495 - 504

• Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

  Agudo A. et al, (2013), Carcinogenesis, 34, 1244 - 1250

• Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort.

  Duell EJ. et al, (2013), Int J Cancer, 132, 2164 - 2175

• Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition.

  Travis RC. et al, (2013), Int J Cancer, 132, 1901 - 1910

• Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition

  Travis RC. et al, (2013), International Journal of Cancer, 132, 1901 - 1910

• Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.

  Allen NE. et al, (2013), Int J Cancer, 132, 635 - 644

• Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition

  Allen NE. et al, (2013), International Journal of Cancer, 132, 635 - 644

• Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

  Fedirko V. et al, (2013), Annals of Epidemiology, 23, 93 - 98

• Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

  Fedirko V. et al, (2013), Ann Epidemiol, 23, 93 - 98

• Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

  Elena JW. et al, (2013), Cancer Causes Control, 24, 13 - 25

• An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.

  Klein AP. et al, (2013), PLoS One, 8

• A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk

  Baltar VT. et al, (2013), European Journal of Epidemiology, 1 - 12

• Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study.

  Agudo A. et al, (2012), J Clin Oncol, 30, 4550 - 4557

• Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.

  Machiela MJ. et al, (2012), Am J Epidemiol, 176, 1121 - 1129

• Meat and heme iron intake and risk of squamous cell carcinoma of the upper aero-digestive tract in the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Steffen A. et al, (2012), Cancer Epidemiol Biomarkers Prev, 21, 2138 - 2148

• Fruit and vegetable consumption and risk of aggressive and non-aggressive urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition.

  Ros MM. et al, (2012), Eur J Cancer, 48, 3267 - 3277

• Characteristics of the Million Women Study participants who have and have not worked at night.

  Wang XS. et al, (2012), Scand J Work Environ Health, 38, 590 - 599

• Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.

  Aleksandrova K. et al, (2012), Cancer Res, 72, 5328 - 5337

• Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition.

  Ros MM. et al, (2012), Am J Clin Nutr, 96, 902 - 910

• Alcohol consumption and risk of type 2 diabetes in European men and women: Influence of beverage type and body sizeThe EPIC-InterAct study

  Beulens JWJ. et al, (2012), Journal of Internal Medicine, 272, 358 - 370

• Alcohol consumption and risk of type 2 diabetes in European men and women: influence of beverage type and body size The EPIC-InterAct study.

  Beulens JW. et al, (2012), J Intern Med, 272, 358 - 370

• Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study.

  Rinaldi S. et al, (2012), Int J Cancer, 131, E1004 - E1014

• UK Biobank: Current status and what it means for epidemiology

  Allen N. et al, (2012), Health Policy and Technology, 1, 123 - 126

• Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition.

  Price AJ. et al, (2012), Cancer Epidemiol Biomarkers Prev, 21, 1531 - 1541

• Plasma cotinine levels and pancreatic cancer in the EPIC cohort study.

  Leenders M. et al, (2012), Int J Cancer, 131, 997 - 1002

• Dietary total antioxidant capacity and gastric cancer risk in the European prospective investigation into cancer and nutrition study.

  Serafini M. et al, (2012), Int J Cancer, 131, E544 - E554

• Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Romieu I. et al, (2012), Am J Clin Nutr, 96, 345 - 355

• Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC.

  Travis RC. et al, (2012), Cancer Causes Control, 23, 1163 - 1171

• Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study.

  Aleksandrova K. et al, (2012), Carcinogenesis, 33, 1211 - 1218

• Dietary intake of heme iron and risk of gastric cancer in the European prospective investigation into cancer and nutrition study.

  Jakszyn P. et al, (2012), Int J Cancer, 130, 2654 - 2663

• A risk model for lung cancer incidence.

  Hoggart C. et al, (2012), Cancer Prev Res (Phila), 5, 834 - 846

• Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.

  Grote VA. et al, (2012), Br J Cancer, 106, 1866 - 1874

• Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study.

  Sala N. et al, (2012), Int J Cancer, 130, 2417 - 2427

• Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.

  Ritte R. et al, (2012), Breast Cancer Res, 14

• Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

  Tsilidis KK. et al, (2012), Am J Epidemiol, 175, 926 - 935

• Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.

  González CA. et al, (2012), Ann Oncol, 23, 1320 - 1324

• Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis.

  Braem MG. et al, (2012), Am J Clin Nutr, 95, 1172 - 1181

• Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.

  Gram IT. et al, (2012), Int J Cancer, 130, 2204 - 2210

• The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.

  Grote VA. et al, (2012), Cancer Epidemiol Biomarkers Prev, 21, 619 - 628

• Biomarkers of oxidative stress and risk of developing colorectal cancer: a cohort-nested case-control study in the European Prospective Investigation Into Cancer and Nutrition.

  Leufkens AM. et al, (2012), Am J Epidemiol, 175, 653 - 663

• Nitrosamines and heme iron and risk of prostate cancer in the European prospective investigation into cancer and nutrition.

  Jakszyn PG. et al, (2012), Cancer Epidemiol Biomarkers Prev, 21, 547 - 551

• Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).

  Lindström S. et al, (2012), Cancer Epidemiol Biomarkers Prev, 21, 437 - 444

• Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.

  Rohrmann S. et al, (2012), Br J Cancer, 106, 1004 - 1010

• Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition

  Rohrmann S. et al, (2012), British Journal of Cancer, 106, 1004 - 1010

• Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

  Duell EJ. et al, (2012), Carcinogenesis, 33, 361 - 367

• A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.

  Wu X. et al, (2012), Hum Mol Genet, 21, 456 - 462

• Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC

  Travis RC. et al, (2012), Cancer Causes and Control, 1 - 9

• Multiple miscarriages are associated with the risk of ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition.

  Braem MG. et al, (2012), PLoS One, 7

• Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium

  Elena JW. et al, (2012), Cancer Causes and Control, 1 - 13

• Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study.

  Rinaldi S. et al, (2011), Cancer Epidemiol Biomarkers Prev, 20, 2532 - 2540

• Endogenous sex steroids and risk of cervical carcinoma: Results from the EPIC study

  Rinaldi S. et al, (2011), Cancer Epidemiology Biomarkers and Prevention, 20, 2532 - 2540

• Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

  Balassiano K. et al, (2011), Cancer Lett, 311, 85 - 95

• Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort.

  Schlehofer B. et al, (2011), Allergy, 66, 1434 - 1441

• Primary brain tumours and specific serum immunoglobulin E: A case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort

  Schlehofer B. et al, (2011), Allergy: European Journal of Allergy and Clinical Immunology, 66, 1434 - 1441

• Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

  Chajès V. et al, (2011), Am J Clin Nutr, 94, 1304 - 1313

• Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study.

  Aleksandrova K. et al, (2011), Cancer Prev Res (Phila), 4, 1873 - 1883

• Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

  Duell EJ. et al, (2011), Am J Clin Nutr, 94, 1266 - 1275

• Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.

  Tsilidis KK. et al, (2011), Br J Cancer, 105, 1436 - 1442

• Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition

  Tsilidis KK. et al, (2011), British Journal of Cancer, 105, 1436 - 1442

• Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.

  James RE. et al, (2011), Cancer Prev Res (Phila), 4, 1626 - 1635

• Genome-wide association study identifies new prostate cancer susceptibility loci

  Schumacher FR. et al, (2011), Human Molecular Genetics, 20, 3867 - 3875

• Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.

  Campa D. et al, (2011), Oncol Rep, 26, 979 - 986

• Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC.

  Timofeeva MN. et al, (2011), Cancer Epidemiol Biomarkers Prev, 20, 2250 - 2261

• Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC

  Timofeeva MN. et al, (2011), Cancer Epidemiology Biomarkers and Prevention, 20, 2250 - 2261

• Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition.

  Rohrmann S. et al, (2011), Cancer Epidemiol Biomarkers Prev, 20, 2174 - 2182

• Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study.

  Michaud DS. et al, (2011), Cancer Prev Res (Phila), 4, 1385 - 1392

• Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition.

  Tsilidis KK. et al, (2011), Cancer Causes Control, 22, 1075 - 1084

• Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition

  Tsilidis KK. et al, (2011), Cancer Causes and Control, 22, 1075 - 1084

• Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): Prospective study of British vegetarians and non-vegetarians

  Crowe FL. et al, (2011), BMJ (Online), 343

• Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): prospective study of British vegetarians and non-vegetarians.

  Crowe FL. et al, (2011), BMJ, 343

• Variety in vegetable and fruit consumption and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition.

  Büchner FL. et al, (2011), Int J Cancer, 128, 2971 - 2979

• Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC).

  Campa D. et al, (2011), Breast Cancer Res Treat, 127, 761 - 767

• Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Ros MM. et al, (2011), Int J Cancer, 128, 2695 - 2708

• Smoking, secondhand smoke, and cotinine levels in a subset of EPIC cohort.

  Baltar VT. et al, (2011), Cancer Epidemiol Biomarkers Prev, 20, 869 - 875

• Diet, vegetarianism, and cataract risk.

  Appleby PN. et al, (2011), Am J Clin Nutr, 93, 1128 - 1135

• Mediterranean dietary pattern and cancer risk in the EPIC cohort.

  Couto E. et al, (2011), Br J Cancer, 104, 1493 - 1499

• Fluid intake and incidence of renal cell carcinoma in UK women

  Allen NE. et al, (2011), British Journal of Cancer, 104, 1487 - 1492

• Fluid intake and incidence of renal cell carcinoma in UK women.

  Allen NE. et al, (2011), Br J Cancer, 104, 1487 - 1492

• Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.

  Tsilidis KK. et al, (2011), Int J Cancer, 128, 1881 - 1889

• Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study.

  Schütze M. et al, (2011), BMJ, 342

• Red meat, dietary nitrosamines, and heme iron and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Jakszyn P. et al, (2011), Cancer Epidemiol Biomarkers Prev, 20, 555 - 559

• Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC).

  van Veldhoven CM. et al, (2011), Eur J Cancer, 47, 748 - 760

• Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC)

  Van Veldhoven CM. et al, (2011), European Journal of Cancer, 47, 748 - 760

• A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Crowe FL. et al, (2011), Ann Hum Biol, 38, 194 - 202

• Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).

  Campa D. et al, (2011), PLoS One, 6

• Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: results from the EPIC-Oxford study.

  Crowe FL. et al, (2011), Public Health Nutr, 14, 340 - 346

• Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).

  Campa D. et al, (2011), Eur J Cancer, 47, 420 - 427

• Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)

  Campa D. et al, (2011), European Journal of Cancer, 47, 420 - 427

• The contribution of risk factors to the higher incidence of invasive and in situ breast cancers in women with higher levels of education in the European prospective investigation into cancer and nutrition.

  Menvielle G. et al, (2011), Am J Epidemiol, 173, 26 - 37

• Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: Results from the EPIC-EURGAST study

  Sala N. et al, (2011), International Journal of Cancer, 7

• Plasma cotinine levels and pancreatic cancer in the EPIC cohort study

  Leenders M. et al, (2011), International Journal of Cancer, 7

• Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition

  Tsilidis KK. et al, (2011), British Journal of Cancer

• Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.

  Bakken K. et al, (2011), Int J Cancer, 128, 144 - 156

• Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

  Purdue MP. et al, (2011), Nature Genetics, 43, 60 - 65

• Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.

  Purdue MP. et al, (2011), Nat Genet, 43, 60 - 65

• Dietary intake of heme iron and risk of gastric cancer in the European prospective investigation into cancer and nutrition study

  Jakszyn P. et al, (2011), International Journal of Cancer, 7

• Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study

  Gram IT. et al, (2011), International Journal of Cancer, 7

• Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Investigation Into Cancer and Nutrition.

  Duell EJ. et al, (2010), Am J Epidemiol, 172, 1384 - 1393

• Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.

  Allen NE. et al, (2010), Am J Epidemiol, 172, 1394 - 1403

• Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.

  Wolpin BM. et al, (2010), Cancer Epidemiol Biomarkers Prev, 19, 3140 - 3149

• Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.

  Tsilidis KK. et al, (2010), Br J Cancer, 103, 1755 - 1759

• Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.

  Gu F. et al, (2010), Cancer Epidemiol Biomarkers Prev, 19, 2877 - 2887

• Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study.

  Michaud DS. et al, (2010), Am J Clin Nutr, 92, 1145 - 1150

• A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.

  Rothman N. et al, (2010), Nat Genet, 42, 978 - 984

• A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

  Rothman N. et al, (2010), Nature Genetics, 42, 978 - 984

• A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

  Rothman N. et al, (2010), Nature Genetics, 42, 978 - 984

• Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.

  Michaud DS. et al, (2010), Cancer Epidemiol Biomarkers Prev, 19, 2562 - 2569

• Serum concentrations of vitamin B12 and folate in British male omnivores, vegetarians and vegans: results from a cross-sectional analysis of the EPIC-Oxford cohort study.

  Gilsing AM. et al, (2010), Eur J Clin Nutr, 64, 933 - 939

• Serum concentrations of vitamin B12 and folate in British male omnivores, vegetarians and vegans: Results from a cross-sectional analysis of the EPIC-Oxford cohort study

  Gilsing AMJ. et al, (2010), European Journal of Clinical Nutrition, 64, 933 - 939

• Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

  Jacobs EJ. et al, (2010), Int J Cancer, 127, 1421 - 1428

• A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

  Lindström S. et al, (2010), J Clin Endocrinol Metab, 95, E121 - E127

• Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition.

  Aleksandrova K. et al, (2010), Am J Epidemiol, 172, 407 - 418

• A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.

  Schumacher FR. et al, (2010), Hum Mol Genet, 19, 3089 - 3101

• Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition.

  Price AJ. et al, (2010), Am J Clin Nutr, 91, 1769 - 1776

• Plasma phytanic acid concentration and risk of prostate cancer: Results from the European prospective investigation into cancer and nutrition

  Price AJ. et al, (2010), American Journal of Clinical Nutrition, 91, 1769 - 1776

• Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.

  Lahmann PH. et al, (2010), Int J Cancer, 126, 2404 - 2415

• Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Boffetta P. et al, (2010), J Natl Cancer Inst, 102, 529 - 537

• Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.

  Rinaldi S. et al, (2010), Int J Cancer, 126, 1702 - 1715

• Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones.

  Key TJ. et al, (2010), Cancer Epidemiol Biomarkers Prev, 19, 960 - 965

• Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.

  Wolpin BM. et al, (2010), Cancer Res, 70, 1015 - 1023

• Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study.

  Buckland G. et al, (2010), Am J Clin Nutr, 91, 381 - 390

• Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC)

  Campa D. et al, (2010), Breast Cancer Research and Treatment, 1 - 7

• Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: results from the EPIC-Oxford study

  Crowe FL. et al, (2010), Public Health Nutrition, 1 - 7

• Consumption of vegetables and fruit and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition.

  Büchner FL. et al, (2009), Int J Cancer, 125, 2643 - 2651

• Alcohol consumption patterns, diet and body weight in 10 European countries.

  Sieri S. et al, (2009), Eur J Clin Nutr, 63 Suppl 4, S81 - 100

• CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.

  Travis RC. et al, (2009), Cancer Epidemiol Biomarkers Prev, 18, 2734 - 2744

• Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

  Johnsen NF. et al, (2009), Int J Cancer, 125, 902 - 908

• A prospective analysis of the association between macronutrient intake and renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition.

  Allen NE. et al, (2009), Int J Cancer, 125, 982 - 987

• Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk.

  McSorley MA. et al, (2009), Int J Cancer, 125, 674 - 679

• Lifestyle factors and serum androgens among 636 middle aged men from seven countries in the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Suzuki R. et al, (2009), Cancer Causes Control, 20, 811 - 821

• Erratum: Lifestyle factors and serum androgens among 636 middle aged men from seven countries in the European prospective investigation into cancer and nutrition (EPIC) (Cancer Causes Control DOI: 10.1007/s10552-009-9326-y)

  Suzuki R. et al, (2009), Cancer Causes and Control, 20, 823 - 824

• Cancer incidence in British vegetarians.

  Key TJ. et al, (2009), Br J Cancer, 101, 192 - 197

• Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition.

  Steffen A. et al, (2009), Cancer Epidemiol Biomarkers Prev, 18, 2079 - 2089

• Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition.

  Travis RC. et al, (2009), Br J Cancer, 100, 1817 - 1823

• Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Travis RC. et al, (2009), Am J Epidemiol, 169, 1223 - 1232

• The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.

  Crowe FL. et al, (2009), Cancer Epidemiol Biomarkers Prev, 18, 1333 - 1340

• The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European prospective investigation into cancer and nutrition

  Crowe FL. et al, (2009), Cancer Epidemiology Biomarkers and Prevention, 18, 1333 - 1340

• Serum vitamin d and risk of prostate cancer in a case-control analysis nested within the european prospective investigation into cancer and nutrition (EPIC)

  Travis RC. et al, (2009), American Journal of Epidemiology, 169, 1223 - 1232

• Mortality in British vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford).

  Key TJ. et al, (2009), Am J Clin Nutr, 89, 1613S - 1619S

• Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition.

  van Duijnhoven FJ. et al, (2009), Am J Clin Nutr, 89, 1441 - 1452

• Cancer incidence in vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford).

  Key TJ. et al, (2009), Am J Clin Nutr, 89, 1620S - 1626S

• Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort.

  Gallo V. et al, (2009), Ann Neurol, 65, 378 - 385

• Reply to B bekaert and MP rayman

  Allen NE., (2009), American Journal of Clinical Nutrition, 89

• Prostate cancer: neither vitamin E nor selenium prevents prostate cancer.

  Allen NE. and Key TJ., (2009), Nat Rev Urol, 6, 187 - 188

• Plasma selenium concentration and prostate cancer risk Reply

  Allen NE. and Investigators EPIC., (2009), AMERICAN JOURNAL OF CLINICAL NUTRITION, 89, 1277 - 1277

• Moderate alcohol intake and cancer incidence in women.

  Allen NE. et al, (2009), J Natl Cancer Inst, 101, 296 - 305

• Association between endogenous plasma hormone concentrations and fracture risk in men and women: the EPIC-Oxford prospective cohort study.

  Roddam AW. et al, (2009), J Bone Miner Metab, 27, 485 - 493

• A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC.

  Suzuki R. et al, (2009), Int J Cancer, 124, 245 - 249

• Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Allen NE. et al, (2008), Am J Clin Nutr, 88, 1567 - 1575

• Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.

  Crowe FL. et al, (2008), Am J Clin Nutr, 88, 1353 - 1363

• Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition

  Crowe FL. et al, (2008), American Journal of Clinical Nutrition, 88, 1353 - 1363

• Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.

  Roddam AW. et al, (2008), Ann Intern Med, 149, 461 - W88

• Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Allen NE. et al, (2008), Endocr Relat Cancer, 15, 485 - 497

• Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition

  Khan AE. et al, (2008), Haematologica, 93, 842 - 850

• Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition.

  Allen NE. et al, (2008), Br J Cancer, 98, 1574 - 1581

• Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition.

  Nieters A. et al, (2008), Am J Epidemiol, 167, 1081 - 1089

• Phytanic acid: measurement of plasma concentrations by gas-liquid chromatography-mass spectrometry analysis and associations with diet and other plasma fatty acids.

  Allen NE. et al, (2008), Br J Nutr, 99, 653 - 659

• Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.

  Endogenous Hormones and Prostate Cancer Collaborative Group None. et al, (2008), J Natl Cancer Inst, 100, 170 - 183

• Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study.

  Johansson M. et al, (2008), Cancer Epidemiol Biomarkers Prev, 17, 279 - 285

• A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women

  Travis RC. et al, (2008), INT J CANCER, 122, 705 - 710

• Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.

  Collaborative Group on Epidemiological Studies of Ovarian Cancer None. et al, (2008), Lancet, 371, 303 - 314

• Physical activity and fracture risk: a prospective study of 1898 incident fractures among 34,696 British men and women.

  Appleby PN. et al, (2008), J Bone Miner Metab, 26, 191 - 198

• Association between plasma 25-hydroxyvitamin D levels and fracture risk: the EPIC-Oxford study.

  Roddam AW. et al, (2007), Am J Epidemiol, 166, 1327 - 1336

• Calcium, diet and fracture risk: a prospective study of 1898 incident fractures among 34 696 British women and men.

  Key TJ. et al, (2007), Public Health Nutr, 10, 1314 - 1320

• Dietary carbohydrates, glycemic index, glycemic load, and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition cohort.

  Cust AE. et al, (2007), Am J Epidemiol, 166, 912 - 923

• Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.

  Travis RC. et al, (2007), Int J Cancer, 121, 1331 - 1338

• The impact of reducing the prostate-specific antigen threshold and including isoform reflex tests on the performance characteristics of a prostate-cancer detection programme.

  Roddam AW. et al, (2007), BJU Int, 100, 514 - 517

• Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study.

  Key TJ. et al, (2007), Am J Clin Nutr, 86, 672 - 681

• Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Linseisen J. et al, (2007), Int J Cancer, 121, 1103 - 1114

• Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.

  Jenab M. et al, (2007), Int J Cancer, 121, 368 - 376

• Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.

  Cust AE. et al, (2007), Int J Cancer, 120, 2656 - 2664

• Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.

  Allen NE. et al, (2007), Cancer Epidemiol Biomarkers Prev, 16, 1121 - 1127

• Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: Results from the European Prospective Investigation into Cancer and Nutrition

  Allen NE. et al, (2007), Cancer Epidemiology Biomarkers and Prevention, 16, 1121 - 1127

• Fruit and vegetable consumption and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

  Rohrmann S. et al, (2007), Cancer Causes and Control, 18, 537 - 549

• C-reactive protein concentrations and subsequent ovarian cancer risk.

  McSorley MA. et al, (2007), Obstet Gynecol, 109, 933 - 941

• Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition.

  Sinilnikova OM. et al, (2007), Cancer Epidemiol Biomarkers Prev, 16, 409 - 415

• Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

  Nagel G. et al, (2007), Int J Epidemiol, 36, 66 - 76

• Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions

  Manuguerra M. et al, (2007), Carcinogenesis, 28, 414 - 422

• Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions.

  Manuguerra M. et al, (2007), Carcinogenesis, 28, 414 - 422

• Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition.

  Lahmann PH. et al, (2007), Cancer Epidemiol Biomarkers Prev, 16, 36 - 42

• Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Rinaldi S. et al, (2007), Cancer Epidemiol Biomarkers Prev, 16, 23 - 29

• Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women.

  Norat T. et al, (2007), Eur J Clin Nutr, 61, 91 - 98

• Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: The European Prospective Investigation into Cancer and Nutrition

  Rinaldi S. et al, (2006), Cancer Causes and Control, 17, 1033 - 1043

• Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC).

  Engeset D. et al, (2006), Int J Cancer, 119, 175 - 182

• IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC).

  Rinaldi S. et al, (2006), Endocr Relat Cancer, 13, 593 - 605

• The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.

  dos Santos Silva I. et al, (2006), Cancer Epidemiol Biomarkers Prev, 15, 449 - 455

• Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.

  Canzian F. et al, (2006), Br J Cancer, 94, 299 - 307

• Prediagnostic serum levels of C-peptide, IGFBP-1, IGFBP-2 and endometrial cancer risk in the EPIC study

  Cust AE. et al, (2006), EUROPEAN JOURNAL OF EPIDEMIOLOGY, 21, 31 - 31

• A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

  Cox DG. et al, (2006), Breast Cancer Res, 8

• Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: Systematic review and meta-analysis. Eur Urol 2005;48 : 386-99 - Reply to C. Stephan, D. Schnorr, S.A. Loening, K. Jung

  Roddam AW. and Allen NE., (2005), EUROPEAN UROLOGY, 48, 1060 - 1061

• Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA Level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol 2005;48:386-99.

  Stephan C. et al, (2005), Eur Urol, 48, 1059 - 1060

• Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.

  Kaaks R. et al, (2005), Endocr Relat Cancer, 12, 1071 - 1082

• Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.

  Canzian F. et al, (2005), Cancer Epidemiol Biomarkers Prev, 14, 2316 - 2325

• Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC).

  Lahmann PH. et al, (2005), Br J Cancer, 93, 582 - 589

• Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.

  Roddam AW. et al, (2005), Eur Urol, 48, 386 - 399

• Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men.

  Rosell MS. et al, (2005), Am J Clin Nutr, 82, 327 - 334

• A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk.

  Allen NE. et al, (2005), Br J Cancer, 92, 1283 - 1287

• A prospective study of diet and prostate cancer in Japanese men.

  Allen NE. et al, (2004), Cancer Causes Control, 15, 911 - 920

• Assessing the clinical impact of prostate-specific antigen assay variability and nonequimolarity: a simulation study based on the population of the United Kingdom.

  Roddam AW. et al, (2004), Clin Chem, 50, 1012 - 1016

• A case--control study of selenium in nails and prostate cancer risk in British men.

  Allen NE. et al, (2004), Br J Cancer, 90, 1392 - 1396

• Diet, nutrition and the prevention of cancer.

  Key TJ. et al, (2004), Public Health Nutr, 7, 187 - 200

• Nutrition and breast cancer.

  Key TJ. et al, (2003), Breast, 12, 412 - 416

• Mortality in British vegetarians: review and preliminary results from EPIC-Oxford.

  Key TJ. et al, (2003), Am J Clin Nutr, 78, 533S - 538S

• Reproducibility over 5 years of measurements of 6-sulphatoxymelatonin in urine samples from postmenopausal women.

  Travis RC. et al, (2003), Cancer Epidemiol Biomarkers Prev, 12, 806 - 808

• Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men.

  Allen NE. et al, (2003), Cancer Epidemiol Biomarkers Prev, 12, 578 - 581

• EPIC-Oxford: lifestyle characteristics and nutrient intakes in a cohort of 33 883 meat-eaters and 31 546 non meat-eaters in the UK.

  Davey GK. et al, (2003), Public Health Nutr, 6, 259 - 269

• Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women.

  Allen NE. et al, (2003), Cancer Causes Control, 14, 65 - 74

• Diet and risk of cancer - Reply

  Key TJ. et al, (2003), LANCET, 361, 257 - 257

• Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

  Keinan-Boker L. et al, (2002), Public Health Nutr, 5, 1217 - 1226

• Physical activity of subjects aged 50-64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC).

  Haftenberger M. et al, (2002), Public Health Nutr, 5, 1163 - 1176

• The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans.

  Allen NE. et al, (2002), Cancer Epidemiol Biomarkers Prev, 11, 1441 - 1448

• The effect of diet on risk of cancer.

  Key TJ. et al, (2002), Lancet, 360, 861 - 868

• Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men.

  Allen NE. et al, (2002), Cancer Causes Control, 13, 353 - 363

• Serum insulin-like growth factor I (IGF-I) concentration in men is not associated with the cytosine-adenosine repeat polymorphism of the IGF-I gene.

  Allen NE. et al, (2002), Cancer Epidemiol Biomarkers Prev, 11, 319 - 320

• Validation study of soya intake and plasma isoflavone levels among British women.

  Verkasalo PK. et al, (2002), IARC Sci Publ, 156, 135 - 136

• The effect of diet on serum insulin-like growth-factor-I and its main binding proteins.

  Allen NE. et al, (2002), IARC Sci Publ, 156, 295 - 296

• Hormones and breast cancer.

  Key TJ. and Allen NE., (2002), IARC Sci Publ, 156, 273 - 276

• Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition).

  Verkasalo PK. et al, (2001), Br J Nutr, 86, 415 - 421

• Re: plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

  Allen NE. and Key TJ., (2001), J Natl Cancer Inst, 93, 649 - 651

• The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.

  Allen NE. et al, (2001), Cancer Epidemiol Biomarkers Prev, 10, 185 - 189

• Energy balance and cancer: the role of sex hormones.

  Key TJ. et al, (2001), Proc Nutr Soc, 60, 81 - 89

• Soy milk intake in relation to serum sex hormone levels in British men.

  Allen NE. et al, (2001), Nutr Cancer, 41, 41 - 46

• Nutrition and breast cancer

  Key TJ. and Allen NE., (2001), Breast, 10, 9 - 13

• The effects of diet on circulating sex hormone levels in men.

  Allen NE. and Key TJ., (2000), Nutr Res Rev, 13, 159 - 184

• Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men.

  Allen NE. et al, (2000), Br J Cancer, 83, 95 - 97

• Selenium and prostate cancer: analysis of individual participant data from fifteen prospective studies

  Allen NE. and travis None., National Cancer Institute

• Prediagnostic circulating concentrations of plasma insulin-like growth factor-I and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition

  Perez-Cornago A. et al, International Journal of Cancer

Recent Publications

• Comparison of sociodemographic and health-related characteristics of UK Biobank participants with the general population

  Fry A. et al, (2017), American Journal of Epidemiology

• UK Biobank: Opportunities for cardiovascular research

  Littlejohns TJ. et al, (2017), European Heart Journal

• Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.

  Fortner RT. et al, (2017), Int J Cancer, 140, 1317 - 1323

• Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research.

  Littlejohns TJ. et al, (2016), Cancer Epidemiol, 45, 40 - 46

• Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies.

  Wu K. et al, (2016), Int J Cancer, 138, 2368 - 2382